UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab

Annals of oncology, 2004-01, Vol.15 (1), p.129-133

2004

Volltextzugriff (PDF)

Shortened First-Line High-Dose Chemotherapy for Patients With Poor-Prognosis Aggressive Lymphoma

Journal of clinical oncology, 2002-05, Vol.20 (10), p.2472-2479

2002

Volltextzugriff (PDF)

Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: A GELA study on 974 patients

Annals of oncology, 2000-06, Vol.11 (6), p.685-690

2000

Volltextzugriff (PDF)

Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma : Updated results of the prospective study LNH87-2

Journal of clinical oncology, 1997-03, Vol.15 (3), p.1131-1137

1997

Volltextzugriff (PDF)

Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years

Journal of clinical oncology, 1997-08, Vol.15 (8), p.2945-2953

1997

Volltextzugriff (PDF)

Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients

Leukemia, 2003-01, Vol.17 (1), p.45-51

2003

Volltextzugriff (PDF)

ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥4 baseline): final results in stage III–IV low-risk Hodgkin lymphoma (IPS 0–2) of the LYSA H34 randomized trial

Annals of oncology, 2014-08, Vol.25 (8), p.1622-1628

2014

Volltextzugriff (PDF)

Rituximab plus CHOP (R-CHOP) overcomes bcl-2—associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)

Blood, 2003-06, Vol.101 (11), p.4279-4284

2003

Volltextzugriff (PDF)

Autologous stem-cell transplantation as consolidation therapy for diffuse large B-cell lymphoma patients with overexpression of bcl-2 protein. Results of the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trial LNH98-B2

Annals of oncology, 2008-03, Vol.19 (3), p.560-565

2008

Volltextzugriff (PDF)

Characteristics and Outcome of Diffuse Large B-Cell Lymphoma in Hepatitis C Virus–Positive Patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte Programs

Journal of clinical oncology, 2006-02, Vol.24 (6), p.953-960

2006

Volltextzugriff (PDF)

ACVBP versus CHOP plus Radiotherapy for Localized Aggressive Lymphoma

The New England journal of medicine, 2005-03, Vol.352 (12), p.1197-1205

2005

Volltextzugriff (PDF)

Survival Benefit of High-Dose Therapy in Poor-Risk Aggressive Non-Hodgkin’s Lymphoma: Final Analysis of the Prospective LNH87–2 Protocol—A Groupe d’Etude des Lymphomes de l’Adulte Study

Journal of clinical oncology, 2000-08, Vol.18 (16), p.3025-3030

2000

Volltextzugriff (PDF)

Intensive Salvage Therapy With High-Dose Chemotherapy for Patients With Advanced Hodgkin’s Disease in Relapse or Failure After Initial Chemotherapy: Results of the Groupe d’Études des Lymphomes de l’Adulte H89 Trial

Journal of clinical oncology, 2002-01, Vol.20 (2), p.467-475

Ferme, C.

2002

Volltextzugriff (PDF)

A multicentre pharmacoepidemiological study of therapeutic practices in invasive fungal infections in France during 1998–1999

Journal of antimicrobial chemotherapy, 2004-08, Vol.54 (2), p.456-464

2004

Volltextzugriff (PDF)

Tumor necrosis factor alpha release is a major biological event associated with rituximab treatment

The hematology journal : the official journal of the European Haematology Association, 2001, Vol.2 (6), p.378-384

2001

Volltextzugriff (PDF)

À vous couper le souffle et les jambes

La Revue de médecine interne (Paris), 2003-06, Vol.24, p.182s-184s

2003

Volltextzugriff (PDF)

Manifestations rénales des vascularites. Étude anatomoclinique et facteurs pronostiques dans une série rétrospective de 60 observations

La revue de medecine interne, 1994, Vol.15, p.24s-24s

1994

Volltextzugriff (PDF)

Central nervous system relapse in patients over 80 years with diffuse large B‐cell lymphoma: an analysis of two LYSA studies

Cancer medicine (Malden, MA), 2018-03, Vol.7 (3), p.539-548

2018

Volltextzugriff (PDF)

Primary Anaplastic Large-Cell Lymphoma in Adults: Clinical Presentation, Immunophenotype, and Outcome

Blood, 1997-11, Vol.90 (9), p.3727-3734

1997

Volltextzugriff (PDF)

Scénarios professionnels. 1

1994

Volltextzugriff (PDF)

Effect of granulocyte colony-stimulating factor administration in elderly patients with aggressive non-Hodgkin's lymphoma treated with a pirarubicin-combination chemotherapy regimen

Annals of oncology, 1996-11, Vol.7 (9), p.966-969

1996

Volltextzugriff (PDF)

Que se cache-t-il sous cette grosse rate ?

La Revue de médecine interne (Paris), 1999, Vol.20, p.311s-312s

1999

Volltextzugriff (PDF)

Sarcome granulocytaire du pancréas sans autre localisation extra-pancréatique

La Presse médicale (1983), 2002-06, Vol.31 (22), p.1024-1026

2002

Volltextzugriff (PDF)

What hides under that large spleen?

La revue de medecine interne, 1999, Vol.20 Suppl 2, p.311s

1999

Volltextzugriff (PDF)

1 – 25 von 236

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(190)
Mit Volltextzugriff
(174)

Publikationsform

Sprache

Französisch
(152)
Englisch
(85)

Erscheinungsjahr

n.n

Thema

Humans
(103)
Male
(69)
Female
(64)
Middle Aged
(62)
Life Sciences & Biomedicine
(61)
Science & Technology
(61)
Adult
(56)
Aged
(38)
Biological And Medical Sciences
(31)
Medical Sciences
(31)
Sciences Biologiques Et Medicales
(24)
Sciences Medicales
(24)
Adolescent
(22)
Life Sciences
(20)
Oncology
(20)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(18)
Pharmacology. Drug Treatments
(16)
Antineoplastic Agents
(15)
Cyclophosphamide - Administration & Dosage
(14)
Doxorubicin - Administration & Dosage
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab

Shortened First-Line High-Dose Chemotherapy for Patients With Poor-Prognosis Aggressive Lymphoma

Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: A GELA study on 974 patients

Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma : Updated results of the prospective study LNH87-2

Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years

Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients

ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥4 baseline): final results in stage III–IV low-risk Hodgkin lymphoma (IPS 0–2) of the LYSA H34 randomized trial

Rituximab plus CHOP (R-CHOP) overcomes bcl-2—associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)

Autologous stem-cell transplantation as consolidation therapy for diffuse large B-cell lymphoma patients with overexpression of bcl-2 protein. Results of the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trial LNH98-B2

Characteristics and Outcome of Diffuse Large B-Cell Lymphoma in Hepatitis C Virus–Positive Patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte Programs

ACVBP versus CHOP plus Radiotherapy for Localized Aggressive Lymphoma

Survival Benefit of High-Dose Therapy in Poor-Risk Aggressive Non-Hodgkin’s Lymphoma: Final Analysis of the Prospective LNH87–2 Protocol—A Groupe d’Etude des Lymphomes de l’Adulte Study

Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation

Intensive Salvage Therapy With High-Dose Chemotherapy for Patients With Advanced Hodgkin’s Disease in Relapse or Failure After Initial Chemotherapy: Results of the Groupe d’Études des Lymphomes de l’Adulte H89 Trial

A multicentre pharmacoepidemiological study of therapeutic practices in invasive fungal infections in France during 1998–1999

Tumor necrosis factor alpha release is a major biological event associated with rituximab treatment

À vous couper le souffle et les jambes

Manifestations rénales des vascularites. Étude anatomoclinique et facteurs pronostiques dans une série rétrospective de 60 observations

Central nervous system relapse in patients over 80 years with diffuse large B‐cell lymphoma: an analysis of two LYSA studies

Primary Anaplastic Large-Cell Lymphoma in Adults: Clinical Presentation, Immunophenotype, and Outcome

Scénarios professionnels. 1

Effect of granulocyte colony-stimulating factor administration in elderly patients with aggressive non-Hodgkin's lymphoma treated with a pirarubicin-combination chemotherapy regimen

Que se cache-t-il sous cette grosse rate ?

Sarcome granulocytaire du pancréas sans autre localisation extra-pancréatique

What hides under that large spleen?

Suchergebnisse filtern